36. A 65year old farmer has presented with difficulty breathing and change of voice for 4 weeks duration. He has habit of chewing tobacco and smoking bidis for many years. (6 Marks) (SMIMER)***** a) What is the probable clinical diagnosis? (Answer :- Carcinoma Larynx) b) How will you examine the patient? c) What findings you expect on your examination? d) After examination you suggest Tracheostomy - but the patient is not willing. How will you counsel the patient? *Cancer larynx. (6 Marks) (NAMO) *A 50 years old male chronic smoker with hoarseness of voice for 1 year /rule out Carcinoma of larynx. Write "T" classification of squamous cell carcinoma Supraglottic according to AJCC. (6 Marks) (GMC) *Enumerate the causes of hoarseness of voice. Describe the clinical features and management of carcinoma larynx. (10 Marks) (KMCRI) *TNM Staging of Ca Supraglottis. (6 Marks) (SMIMER)

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
I now have comprehensive data to write a complete, exam-quality answer. Let me compile everything.

Carcinoma of the Larynx - Complete Exam Answer

Probable Clinical Diagnosis

Carcinoma of the Larynx (most likely Squamous Cell Carcinoma - glottic or supraglottic)
Rationale:
  • 65-year-old male farmer
  • Hoarseness (change of voice) for 4 weeks - the cardinal symptom of glottic carcinoma
  • Difficulty breathing (dyspnea) - suggests significant tumor bulk or subglottic extension causing airway compromise
  • Long-standing tobacco chewing + bidi smoking = two major independent risk factors, acting synergistically
  • 90% of laryngeal cancers occur after age 40 in tobacco users; M:F ratio 7:1

b) How Will You Examine the Patient?

General Examination

  • General condition, built, nutrition, pallor, cachexia
  • Respiratory rate, SpO2, stridor (inspiratory = supraglottic, biphasic = glottic/subglottic)
  • Cervical lymphadenopathy - level II, III, IV nodes (palpate both sides)

Local Examination

External Laryngeal Examination:
  • Inspect neck for swelling, fullness, prominent laryngeal cartilages
  • Palpate larynx - loss of crepitus on rocking larynx over spine (Muller's sign / "cricoid click" - Murat's sign) suggests post-cricoid/subglottic spread
  • Palpate thyroid cartilage for tenderness or destruction
  • Palpate hyoid bone
  • Palpate bilateral cervical lymph nodes systematically (Levels I-VI)
Indirect Laryngoscopy (Mirror Examination):
  • Use a size 5 or 6 laryngeal mirror
  • Visualize: epiglottis, aryepiglottic folds, arytenoids, false cords, true vocal cords (TVCs), anterior commissure, posterior commissure, piriform fossae, subglottis
  • Assess vocal cord mobility - pooling of saliva in pyriform fossa (suggests impaired swallowing/hypopharyngeal involvement)
  • Note: color, surface (ulceration, exophytic growth, leukoplakia), extent
Fibreoptic Nasopharyngolaryngoscopy (FNLS):
  • Superior to mirror examination
  • Dynamic assessment of vocal cord movements, subglottic extension, arytenoid involvement

Investigations to Order

InvestigationPurpose
CT scan neck with contrastExtent of tumor, cartilage invasion, nodal disease
MRI neckSoft tissue detail, pre-epiglottic/paraglottic space invasion
CXR / CT chestPulmonary metastasis, second primary
Microlaryngoscopy + biopsy under GADefinitive diagnosis and histology
PET-CTStaging, distant metastasis
LFT, RFT, CBCPre-operative workup

c) Expected Examination Findings

On Indirect Laryngoscopy:

  • Glottic tumor (most common): Pearly-gray/white, irregular, ulcerated lesion on one or both vocal cords; restricted or absent vocal cord mobility; cord may be fixed (indicates T3)
  • Supraglottic tumor: Mass on epiglottis, aryepiglottic folds, or false cords; pooling of saliva in pyriform fossa
  • Anterior commissure involvement: lesion bridging both cords
  • Mucosal irregularity, ulceration, or exophytic mass
  • Adjacent mucosa may show leukoplakia / erythroplakia

On Neck Examination:

  • Glottic Ca: Often NO lymph nodes (glottis has sparse lymphatics; N0 is common at presentation)
  • Supraglottic Ca: Palpable cervical lymphadenopathy in 25-50% of cases at presentation, typically ipsilateral Levels II, III, IV; bilateral nodes if midline tumor
  • Thyroid cartilage tenderness or palpable destruction - T4a disease

General:

  • Stridor (biphasic = critical airway)
  • Reduced vocal cord mobility or fixation
  • Weight loss, dysphagia if advanced disease

d) Counseling the Patient Refusing Tracheostomy

Why Tracheostomy is Recommended:

When the tumor is causing significant airway compromise (stridor, dyspnea), tracheostomy is necessary to:
  1. Secure the airway before definitive treatment (radiation or surgery)
  2. Prevent acute airway obstruction - which can be fatal (sudden death from asphyxia)
  3. Allow safer administration of anesthesia for microlaryngoscopy and biopsy
  4. Enable definitive treatment - radiation therapy can cause initial tumor swelling, worsening obstruction

Counseling Points (Patient-Centered Approach):

Explain the danger:
"You have a growth in your voice box that is narrowing your airway. Your breathing difficulty will worsen - without securing the airway, you risk suffocating suddenly, even at rest or during sleep."
Address fears:
  • Many patients fear tracheostomy = permanent disability or loss of voice
  • Clarify: Tracheostomy can be temporary - it is a bridge to definitive treatment; in many cases it can be closed after laryngeal rehabilitation
  • Explain the procedure is performed under anesthesia and is relatively safe
Explain consequences of refusal:
  • Progressive dyspnea leading to acute respiratory failure
  • Risk of aspiration pneumonia
  • Emergency tracheostomy in crisis is far more dangerous than planned one
Explain treatment pathway:
  • After airway is secured → biopsy → staging → curative treatment (radiation ± surgery)
  • Without airway security → definitive treatment cannot be safely initiated
  • If cancer is early stage, voice preservation may still be possible with radiation or conservation surgery
Involve family members with patient's consent.
Document the counseling and informed refusal appropriately.
Offer alternatives if applicable:
  • In selected cases, radiation can be started without tracheostomy if the tumor is not critically obstructing; however, this requires close monitoring in a hospital setting
  • If patient refuses despite full counseling, document the refusal, ensure patient has 24-hour emergency access, and involve hospital ethics committee if needed

TNM Staging - Carcinoma of Supraglottis (AJCC 8th Edition)

(As asked in NAMO/GMC/SMIMER questions)

T Classification - Supraglottis:

StageDescription
T1Tumor limited to one subsite of supraglottis, with normal vocal cord mobility
T2Tumor invades more than one subsite of supraglottis, or extends outside supraglottis (mucosa of base of tongue, vallecula, medial wall of piriform sinus), without fixation of larynx
T3Tumor limited to larynx with vocal fold fixation, OR invades postcricoid area, pre-epiglottic space, paraglottic space, or inner cortex of thyroid cartilage
T4aModerately advanced - invades thyroid cartilage (outer cortex), or extends into trachea, soft tissues of neck (strap muscles), thyroid gland, or esophagus
T4bVery advanced - invades prevertebral fascia, encases carotid artery, or invades mediastinal structures

Subsites of Supraglottis:

  • Suprahyoid epiglottis
  • Infrahyoid epiglottis
  • Aryepiglottic folds (laryngeal aspect)
  • Arytenoids
  • False (ventricular) cords

N Classification (same for all larynx Ca):

StageDescription
N0No regional nodes
N1Single ipsilateral node ≤3 cm, no extranodal extension (ENE)
N2aSingle ipsilateral node >3 cm and ≤6 cm, no ENE; OR single ipsilateral node ≤3 cm with ENE(+)
N2bMultiple ipsilateral nodes ≤6 cm, no ENE
N2cBilateral or contralateral nodes ≤6 cm, no ENE
N3aAny node >6 cm, no ENE
N3bAny node with clinical ENE(+)

M Classification:

  • M0: No distant metastasis
  • M1: Distant metastasis present (most common site: lungs)

Overall Stage Grouping:

StageTNM
IT1N0M0
IIT2N0M0
IIIT3N0M0 OR T1-T3
IVAT4aN0-N2M0 OR T1-T3
IVBT4bAny NM0 OR Any T
IVCAny TAny NM1

Causes of Hoarseness of Voice (for KMCRI 10-mark question)

Laryngeal Causes:

  • Malignant: Carcinoma larynx (most important to exclude)
  • Benign tumors: Polyp, nodule, papilloma, cyst, fibroma
  • Inflammatory: Acute/chronic laryngitis, laryngeal TB, laryngeal syphilis
  • Traumatic: Intubation injury, neck injury
  • Systemic: Amyloidosis, pemphigus, sarcoidosis

Non-Laryngeal Causes (Recurrent Laryngeal Nerve Palsy):

  • Mediastinal: Carcinoma esophagus/bronchus, mediastinal lymphadenopathy, aortic aneurysm, mitral stenosis (Ortner's syndrome)
  • Neck: Thyroid carcinoma, thyroidectomy injury
  • Central: Bulbar palsy, syringomyelia, MS, stroke
  • Idiopathic

Functional/Other:

  • Functional dysphonia
  • Conversion aphonia
  • Hypothyroidism (myxedema voice)
  • Androphonia (puberphonia)

Key Points Summary for Exam:
  • Probable diagnosis = Carcinoma Larynx (SCC, likely glottic given hoarseness as predominant symptom)
  • 95% of laryngeal Ca = SCC; tobacco is the #1 risk factor
  • Indirect laryngoscopy is the key bedside examination - assess cord mobility and tumor extent
  • Tracheostomy refusal = explain life-threatening airway risk, temporary nature, treatment dependency
  • Supraglottic T-staging: T1 (one subsite) → T2 (multi-subsite, no fixation) → T3 (fixation) → T4a (thyroid cartilage) → T4b (carotid/prevertebral/mediastinum)
(Sources: Cummings Otolaryngology Head and Neck Surgery; K.J. Lee's Essential Otolaryngology; Robbins & Kumar Basic Pathology)
This is a shared conversation. Sign in to Orris to start your own chat.